Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Moore

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
American Journal of Diseases of Children (1960)|February 1, 1991
Focal scleroderma and severe cardiomyopathy. Patient report and brief reviewE C Moore, F Cohen, Z Farooki, et al.
Annals of the Rheumatic Diseases|March 1, 1992
Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defectE C Moore, F Cohen, S D Douglas, et al.
Cancer Treatment Reports|January 1, 1979
Enzymatic assay for the antitumor agent-N-(phosphonacetyl)-L-aspartic acid (PALA)J Friedman, E C Moore, S W Hall, et al.
The New England Journal of Medicine|February 8, 1990
Zidovudine overdose in a childE C Moore, F Cohen, R E Kauffman, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Blau syndrome (familial granulomatous arthritis, iritis, and rash) in an african-american familyI A Cuesta, E C Moore, R Rabah, et al.
Biochemistry|November 10, 1970
Inhibition of ribonucleoside diphosphate reductase by 1-formylisoquinoline thiosemicarbazone and related compoundsE C Moore, M S Zedeck, K C Agrawal, et al.
Molecular Pharmacology|November 1, 1980
Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumorP J Preidecker, K C Agrawal, A C Sartorelli, et al.
Journal of Medicinal Chemistry|November 1, 1972
Potential antitumor agents. 6. Possible irreversible inhibitors of ribonucleoside diphosphate reductaseK C Agrawal, B A Booth, E C Moore, et al.
Advances in Enzyme Regulation|January 1, 1976
Characterization of the biochemical mechanism of action of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazonesA C Sartorelli, K C Agrawal, A S Tsiftsoglou, et al.
Cancer Research|June 1, 1974
Alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone inhibitors of ribonucleoside diphosphate reductaseB A Booth, K C Agrawal, E C Moore, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
American Journal of Diseases of Children (1960)|February 1, 1991
Focal scleroderma and severe cardiomyopathy. Patient report and brief reviewE C Moore, F Cohen, Z Farooki, et al.
Annals of the Rheumatic Diseases|March 1, 1992
Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defectE C Moore, F Cohen, S D Douglas, et al.
Cancer Treatment Reports|January 1, 1979
Enzymatic assay for the antitumor agent-N-(phosphonacetyl)-L-aspartic acid (PALA)J Friedman, E C Moore, S W Hall, et al.
The New England Journal of Medicine|February 8, 1990
Zidovudine overdose in a childE C Moore, F Cohen, R E Kauffman, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Blau syndrome (familial granulomatous arthritis, iritis, and rash) in an african-american familyI A Cuesta, E C Moore, R Rabah, et al.
Biochemistry|November 10, 1970
Inhibition of ribonucleoside diphosphate reductase by 1-formylisoquinoline thiosemicarbazone and related compoundsE C Moore, M S Zedeck, K C Agrawal, et al.
Molecular Pharmacology|November 1, 1980
Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumorP J Preidecker, K C Agrawal, A C Sartorelli, et al.
Journal of Medicinal Chemistry|November 1, 1972
Potential antitumor agents. 6. Possible irreversible inhibitors of ribonucleoside diphosphate reductaseK C Agrawal, B A Booth, E C Moore, et al.
Advances in Enzyme Regulation|January 1, 1976
Characterization of the biochemical mechanism of action of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazonesA C Sartorelli, K C Agrawal, A S Tsiftsoglou, et al.
Cancer Research|June 1, 1974
Alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone inhibitors of ribonucleoside diphosphate reductaseB A Booth, K C Agrawal, E C Moore, et al.
Pageof 7